More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$9.17B
EPS
3.65
P/E ratio
24.4
Price to sales
0.69
Dividend yield
--
Beta
0.865822
Previous close
$84.96
Today's open
$84.15
Day's range
$82.80 - $85.58
52 week range
$68.70 - $92.18
show more
CEO
Stanley M. Bergman
Employees
25000
Headquarters
Melville, NY
Exchange
Nasdaq Global Select
Shares outstanding
110538542
Issue type
Common Stock
Healthcare
Medical Distributors
Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

Henry Schein Updates Presentation of Non-GAAP Financial Measures
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced an update to its presentation of certain non-GAAP financial measures. Beginning with its fourth-quarter 2026 financial results, Henry Schein will exclude the gains resulting from the remeasurement to fair value of previously held equity interests from its non-GAAP financial results. These gains arise when the.
Business Wire • Nov 16, 2026

CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration
BOSTON & MELVILLE, N.Y.--(BUSINESS WIRE)--CareQuest Institute and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration.
Business Wire • Nov 10, 2026

Is Henry Schein (HSIC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Nov 5, 2026

Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 5, 2026

Henry Schein (HSIC) Upgraded to Buy: What Does It Mean for the Stock?
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Nov 5, 2026

Is Henry Schein (HSIC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Henry Schein (HSIC) possesses solid growth attributes, which could help it handily outperform the market.
Zacks Investment Research • Nov 5, 2026

Henry Schein to Participate in Upcoming Investor Conferences in November and December
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November and December: Jefferies Healthcare Conference at the Waldorf Hilton, London on November 17, 2026, at 9:00 a.m. Greenwich Time/4:00 a.m. Eastern time. Piper Sandler's Healthcare Conference at the Lotte New York Palace Hotel, New York.
Business Wire • Nov 5, 2026

HSIC vs. MMSI: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Nov 5, 2026

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Henry Schein Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.